Dec. 29, 2025 8:00 AM ETARS Pharmaceuticals, Inc. (SPRY) neffy contains epinephrine, a medicine used to treat allergic emergencies (anaphylaxis). Anaphylaxis can be life-threatening, can happen in ...
Current medical guidelines discourage the use of combined oral contraceptives (COCs) among people who experience migraine with aura—a type of migraine accompanied by temporary neurological ...
The approval marks Cardamyst as the first FDA-approved treatment in over 30 years for more than 2 million Americans with PSVT. Cardamyst nasal spray is a novel and rapid-acting calcium channel blocker ...
Guideline states that prochlorperazine IV and greater occipital nerve blocks must be offered to eligible adults requiring parenteral therapy. HealthDay News — The American Headache Society has updated ...
THURSDAY, Dec. 11, 2025 (HealthDay News) -- The American Headache Society has updated the guidelines on the use of parenteral pharmacologic therapies for management of migraine attacks in the ...
AbbVie is seeking European approval of expanded use of its migraine drug atogepant in adults following strong results from a phase three study. The North Chicago drugmaker is presenting results of ...
The FDA approved dihydroergotamine (DHE) nasal powder (Atzumi) 5.2 mg to treat acute migraine with or without aura in adults, Satsuma Pharmaceuticals announced Wednesday. The product is the only DHE ...
SAN DIEGO -- An investigational device that delivered conditioned room air intranasally treated acute migraine attacks without drugs, a randomized sham-controlled study showed. Compared with sham, ...
Anal lubricants often contain lidocaine as a numbing agent and chemistry can separate and isolate the active compound. Half a million bottles of blood pressure drug recalled for high carcinogen levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback